ERYTECH Pharma S.A. Statistics Share Statistics ERYTECH Pharma S.A. has 60.75M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 60.75M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 27.99M Failed to Deliver (FTD) Shares 165 FTD / Avg. Volume 0.11%
Short Selling Information The latest short interest is 17.79K, so 0.05% of the outstanding
shares have been sold short.
Short Interest 17.79K Short % of Shares Out 0.05% Short % of Float n/a Short Ratio (days to cover) 1.69
Valuation Ratios The PE ratio is -41.94 and the forward
PE ratio is null.
ERYTECH Pharma S.A.'s PEG ratio is
0.42.
PE Ratio -41.94 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.41 P/FCF Ratio -0.3 PEG Ratio 0.42
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ERYTECH Pharma S.A..
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.65,
with a Debt / Equity ratio of 0.58.
Current Ratio 3.65 Quick Ratio 3.54 Debt / Equity 0.58 Debt / EBITDA -0.6 Debt / FCF -0.43 Interest Coverage -2.05
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-4.65K Employee Count 49 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 521K Effective Tax Rate 177.82%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 2.13, so ERYTECH Pharma S.A.'s
price volatility has been higher than the market average.
Beta 2.13 52-Week Price Change n/a 50-Day Moving Average 0.88 200-Day Moving Average 0.74 Relative Strength Index (RSI) 42.5 Average Volume (20 Days) 148,586
Income Statement
Revenue n/a Gross Profit n/a Operating Income -2.8M Net Income -228K EBITDA -22.69M EBIT 1.66M Earnings Per Share (EPS) -0.01
Full Income Statement Balance Sheet The company has 38.79M in cash and 13.57M in
debt, giving a net cash position of 25.22M.
Cash & Cash Equivalents 38.79M Total Debt 13.57M Net Cash 25.22M Retained Earnings -228K Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -31.76M
and capital expenditures -85K, giving a free cash flow of -31.85M.
Operating Cash Flow -31.76M Capital Expenditures -85K Free Cash Flow -31.85M FCF Per Share -1.03
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
